nicardipine has been researched along with Critical Illness in 4 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study suggests that nicardipine is a more effective antihypertensive agent than labetalol in an unselected group of patients who develop hypertension in the intensive care unit setting." | 9.16 | Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients. ( Hilleman, DE; Malesker, MA, 2012) |
| " Nicardipine and labetalol are commonly administered for the treatment of acute hypertension following stroke." | 7.91 | Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke. ( Desai, A; Hanni, C; Mohamed, W; Parker, D; Saber, H; Sadeghi, M; Singh, A, 2019) |
| "Our study suggests that nicardipine is a more effective antihypertensive agent than labetalol in an unselected group of patients who develop hypertension in the intensive care unit setting." | 5.16 | Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients. ( Hilleman, DE; Malesker, MA, 2012) |
| " Nicardipine and labetalol are commonly administered for the treatment of acute hypertension following stroke." | 3.91 | Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke. ( Desai, A; Hanni, C; Mohamed, W; Parker, D; Saber, H; Sadeghi, M; Singh, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sadeghi, M | 1 |
| Saber, H | 1 |
| Singh, A | 1 |
| Hanni, C | 1 |
| Parker, D | 1 |
| Desai, A | 1 |
| Mohamed, W | 1 |
| Wong, MF | 1 |
| Yen, ZS | 1 |
| Marik, PE | 1 |
| Rivera, R | 1 |
| Malesker, MA | 1 |
| Hilleman, DE | 1 |
1 review available for nicardipine and Critical Illness
| Article | Year |
|---|---|
Hypertensive emergencies: an update.
Topics: Acute Disease; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Critical Care; | 2011 |
1 trial available for nicardipine and Critical Illness
| Article | Year |
|---|---|
Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Critical Illness; Female; Hospital Charges; Humans; H | 2012 |
2 other studies available for nicardipine and Critical Illness
| Article | Year |
|---|---|
Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Critical Illness; Databases, Factual; | 2019 |
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1. Nicardipine hydrochloride for hypertensive crisis in patients with aortic dissection.
Topics: Aortic Aneurysm; Aortic Dissection; Critical Illness; Emergency Medicine; Emergency Service, Hospita | 2011 |